MBAI

↓ PDF (Pro)

Check-Cap Ltd. Ordinary Share

HealthcareDiagnostics & ResearchIsraelNASDAQ

$1.42

+2.16%today

MKT CAP

$10M

-20.2% · 1Y

Earnings History

+35.2%

-2.7%

-77.9%

-154.2%

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Full Financials

Trailing P/E2.2x

Forward P/E-

EV/EBITDA-4.5x

Price/Sales-

Dividend Yield-

Revenue Growth YoY-

Earnings Growth YoY-

Revenue Growth QoQ-

5y Revenue CAGR-

5y Earnings CAGR-

Gross Margin0.0%

Operating Margin0.0%

Net Margin0.0%

ROE416.7%

Debt / Equity0.47x

Free Cash Flow$846,875

Insider Ownership20.8%

Institutional Ownership0.7%

Short % of Float2.85%

Days to Cover1.6d

1 Week-1.4%

1 Month-

3 Months-

6 Months-

YTD-

1 Year-

3 Years-

5 Years-

vs 50-day SMA-

vs 200-day SMA-

vs 52w High-

vs 52w Low-

Top Holders

Holder	Type	% Held	Value	Δ Shares	As of
UBS Group AG	institution	0.39%	$0.00B	+184.76%	2026-03-31
BNP Paribas Financial Markets	institution	0.21%	$0.00B	-42.52%	2025-12-31
DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Micro Cap Portfolio	fund	0.13%	$0.00B	-14.40%	2026-01-31
National Bank of Canada/FI/	institution	0.06%	$0.00B	+0.00%	2025-12-31
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund	fund	0.05%	$0.00B	+0.00%	2026-02-28
JPMORGAN CHASE & CO	institution	0.03%	$0.00B	-50.00%	2025-12-31
Morgan Stanley	institution	0.02%	$0.00B	-79.71%	2025-12-31
Bank of America Corporation	institution	0.01%	$0.00B	+0.00%	2025-12-31
Harbour Investments, Inc.	institution	0.00%	$0.00B	-57.14%	2025-12-31
Aviso Financial Inc.	institution	0.00%	$0.00B	+0.00%	2025-12-31
Osaic Holdings Inc.	institution	0.00%	$0.00B	+141.18%	2025-12-31
Royal Bank of Canada	institution	0.00%	$0.00B	+0.00%	2025-12-31

Peers

Compare side-by-side →

Ticker	Cap	Score	P/E	Fwd P/E	EV/EBITDA	ROE	Gross	D/E	Div
FONR Fonar Corporation Common Stock	$119M	80	16.4	-	-	-	-	-	0.00%
BDSX Biodesix Inc. Common Stock	$151M	-	-	-	-	-	-	-	0.00%
IMDX Insight Molecular Diagnostics Inc. Common Stock	$158M	-	-	-	-	-	-	-	0.00%
BNR Burning Rock Biotech Limited American Depositary Shares	$186M	-	-	-	-	-	-	-	0.00%
PRE Prenetics Global Limited Class A Ordinary Share	$271M	-	-	-	-	-	-	-	0.00%
MYGN Myriad Genetics Inc. Common Stock	$386M	40	-	31.5	-	-23.5%	68%	32.84	0.00%